Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
Chan SK, Lin C, Huang SH, Chau TC, Guo QJ, O'Sullivan B, Lam KO, Chau SC, Chan SY, Tong CC, Vardhanabhuti V, Kwong DLW, So TH, Ng CY, Leung TW, Luk MY, Lee AWM, Choi HCW, Pan JJ, Lee VHF. Chan SK, et al. Among authors: vardhanabhuti v. Oral Oncol. 2022 Mar;126:105736. doi: 10.1016/j.oraloncology.2022.105736. Epub 2022 Feb 1. Oral Oncol. 2022. PMID: 35121396
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Chan SK, Chan SY, Choi HC, Tong CC, Lam KO, Kwong DL, Vardhanabhuti V, Leung TW, Luk MY, Lee AW, Lee VH. Chan SK, et al. Among authors: vardhanabhuti v. Front Oncol. 2020 Aug 21;10:1417. doi: 10.3389/fonc.2020.01417. eCollection 2020. Front Oncol. 2020. PMID: 32974150 Free PMC article.
Radiomics Model to Predict Early Progression of Nonmetastatic Nasopharyngeal Carcinoma after Intensity Modulation Radiation Therapy: A Multicenter Study.
Du R, Lee VH, Yuan H, Lam KO, Pang HH, Chen Y, Lam EY, Khong PL, Lee AW, Kwong DL, Vardhanabhuti V. Du R, et al. Among authors: vardhanabhuti v. Radiol Artif Intell. 2019 Jul 10;1(4):e180075. doi: 10.1148/ryai.2019180075. eCollection 2019 Jul. Radiol Artif Intell. 2019. PMID: 33937796 Free PMC article.
Prognostic and therapeutic evaluation of nasopharyngeal carcinoma by dynamic contrast-enhanced (DCE), diffusion-weighted (DW) magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS).
Mui AWL, Lee AWM, Lee VHF, Ng WT, Vardhanabhuti V, Man SSY, Chua DTT, Law SCK, Guan XY. Mui AWL, et al. Among authors: vardhanabhuti v. Magn Reson Imaging. 2021 Nov;83:50-56. doi: 10.1016/j.mri.2021.07.003. Epub 2021 Jul 8. Magn Reson Imaging. 2021. PMID: 34246785 Review.
PET/CT: Nasopharyngeal Cancers.
Xie C, Vardhanabhuti V. Xie C, et al. Among authors: vardhanabhuti v. PET Clin. 2022 Apr;17(2):285-296. doi: 10.1016/j.cpet.2021.12.006. Epub 2022 Mar 4. PET Clin. 2022. PMID: 35256301 Review.
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
Chan SK, O'Sullivan B, Huang SH, Chau TC, Lam KO, Chan SY, Tong CC, Vardhanabhuti V, Kwong DL, Ng CY, Leung TW, Luk MY, Lee AW, Choi HC, Lee VH. Chan SK, et al. Among authors: vardhanabhuti v. Cancers (Basel). 2022 Apr 11;14(8):1923. doi: 10.3390/cancers14081923. Cancers (Basel). 2022. PMID: 35454830 Free PMC article.
99 results